Abstract
Exhaled nitric oxide fraction (FeNO) has been proposed as a noninvasive marker of eosinophilic bronchial inflammation in active asthma, and supposed to reflect responsiveness to corticosteroid therapy. There are several factors influencingFeNO, and its role in early childhood respiratory disorders needs to be established.Between 2004 and 2008, 444 children aged –26.7 months), successfully underwent measurement ofFeNO, lung function tests, and a dosimetric methacholine challenge test.The median level ofFeNOwas 19.3 ppb (interquartile range 12.3–26.9 ppb). ElevatedFeNO(≥27 ppb, the highest quartile) was associated with maternal history of asthma (adjusted OR 3.2, 95% CI 1.3–8.1; p=0.012), and increased airway responsiveness (the provocative dose of methacholine causing a 40% fall in maximal expiratory flow at functional residual capacity ≤0.30 mg) (adjusted OR 4.1, 95% CI 1.4–12.7; p=0.012). Atopy, blood eosinophilia and lung function were not associated with elevatedFeNO.In conclusion, maternal history of asthma, and increased airway responsiveness are associated with elevatedFeNOin infants with recurrent lower respiratory tract symptoms.

This publication has 34 references indexed in Scilit: